SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as the community rallies around its vision of blending crypto with cannabis culture, emphasizing freedom and growth. Community members are excited about Weedcoin's potential in the evolving digital landscape, viewing it as more than just a token but a movement.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending as investors react to news of a partnership with Corning to scale up production of ceramic separators for its solid-state batteries, which many believe validates the path towards commercialization. The community is discussing the potential impact on production timelines and OEM interest, viewing it as a key step in shifting from science to industrial mode. Some investors are seeing this as a turning point, while others remain cautious and await further confirmation.

Draganfly, Inc. engages in the manufacture and sale of commercial unmanned aerial vehicle systems and software serving the public safety, agriculture, industrial inspections, security, mapping, and surveying markets. Its products include quad-copters, fixed wing aircrafts, ground based robots, hand held controllers, and software used for tracking, live streaming, and data collection. The firm also offers custom engineering, training, simulation consulting, as well as data and flight training services. The company was founded by Zenon Dragan and Christine Dragan in 1998 and is headquartered in Saskatoon, Canada.

Draganfly Inc

Draganfly ($DPRO) is trending due to news of being selected by the U.S. Army to supply drone systems, sparking significant pre-market surge. Community chatter highlights the stock's tight float, potential for a short squeeze, and anticipation for further contract news. Bullish sentiment is fueled by the company's involvement in the defense sector and potential benefits from a possible ban on DJI drones.

Wolfspeed, Inc. is an innovator of wide bandgap semiconductors, focused on silicon carbide and gallium nitride (GaN) materials and devices for power and radiofrequency (RF) applications. Its product families include silicon carbide and GaN materials, power devices and RF devices, and its products are targeted for various applications such as electric vehicles, fast charging, 5G, renewable energy and storage, and aerospace and defense. The company was founded by Calvin H. Carter Jr., John W. Palmour, F. Neal Hunter, Eric Hunter, and John Edmond in 1987 and is headquartered in Durham, NC.

Wolfspeed Inc - Ordinary Shares (New)

Wolfspeed Inc

Wolfspeed ($WOLF) is trending due to its emergence from Chapter 11 bankruptcy and subsequent stock restructuring, leading to extreme price volatility. The community is actively discussing the impact of the share cancellation and reissuance on existing shareholders, as well as the potential for a short squeeze given the reduced float and high short interest.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

CELH is trending following an upgrade from Morgan Stanley, sparking community excitement around potential price appreciation and further upgrades. Bullish sentiment is fueled by the company's strong sales, the Pepsi distribution deal, and cup and handle pattern formations. Some traders are noting high option volume, while others advise caution due to the stock's volatility.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending due to a significant drop following mixed results from Phase 3 trials, specifically related to the HiSCR75 endpoint, leading to a wide-ranging discussion about the drug's efficacy and future prospects; however, some believe the market has overreacted, citing the drug's potential and the company's cash reserves. The community is weighing the impact of the data, analyst downgrades, and potential for a buyout.

Carnival Corp. engages in the operation of cruise ships. It operates through the following business segments: North America and Australia (NAA) Cruise, Europe and Asia (EA) Cruise Operations, Cruise Support, and Tour and Others. The North America and Australia (NAA) Cruise segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe and Asia (EA) Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corp. - Ordinary Shares (Paired Stock)

Carnival Corp

Carnival is trending as analysts issue positive ratings and price target increases, generating community discussion about potential upside. News of strong demand, fleet modernization, and strategic initiatives like Celebration Key are also circulating. Some traders are taking profits, while others see a long-term buying opportunity as the company recovers and reduces debt.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU.X is trending as the community rallies around its strong IRL presence and diverse range of products, including energy drinks and merchandise. The community's dedication and continuous building efforts are fueling excitement, with many believing KENDU has the potential to reach a billion-dollar market cap. Discussions highlight the growing holder count and the project's unique approach to combining a strong community with real-world businesses.

Jupiter is a cryptocurrency exchange platform on the Solana blockchain, offering features such as token swapping, limit orders, dollar-cost averaging, and a bridge for asset transfers to Solana. It provides users with tools to find the best trading prices and includes a beta version for perpetual futures trading. Jupiter finds the best price route for your swap by aggregating all the major liquidity sources on Solana.

Jupiter

$JUP.X is trending due to community excitement around $UPDOG.X, a Solana-based meme coin listed on Jupiter's strict list. Community members are actively discussing strategies to increase $UPDOG.X's visibility and adoption, while highlighting its potential for high returns within the Solana ecosystem.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power ($SMR) is trending due to a BofA downgrade to Underperform, causing community concern and shorting. Despite positive long-term outlooks and potential for nuclear in data centers, immediate reactions are bearish with some anticipating a drop. Discussions also involve Fluor's recent share sales and comparisons to sector peers like $OKLO.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Theratechnologies Inc. (THTX) traded 46% higher on Friday noon after Michigan-based Future Pak LLC announced that it has submitted a fresh proposal to acquire all outstanding shares of the company’s common stock.Future Pak is a privately held contract manufacturer and packager of pharmaceutical and nutraceutical products.The company’s new proposal offers a cash consideration of $3.51 to $4.50 per share, implying a premium of 164% to 238% on Theratechnologies’ closing price of $1.33 on Thursday.The proposal represents an enterprise value of up to $255 million, including $205 million in cash and up to $50 million in contingent value right payments.Future Pak said the offer remains open for consideration by Theratechnologies and its Board. The contract manufacturer highlighted that it has submitted two formal proposals to Theratechnologies since January, including the recent proposal, but received minimal engagement from the company.Future Pak Chief Growth Officer Nirav Patel said the firm believes the proposal provides a “significant upside” and a “solid foundation” for constructive dialogue.The company added that the proposed transaction would not be subject to a financing contingency and has the full support of its strategic financial partner, Colbeck Capital Management.On Stocktwits, retail sentiment around Theratechnologies rose from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours while message volume jumped from ‘extremely low’ to ‘extremely high.’<figure class="image"><img style="aspect-ratio:1292/308;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_11_at_12_39_25_PM_png_ebb8e8c704.webp" alt="THTX's Sentiment Meter and Message Volume as of 12:40 p.m. ET on April 11, 2025 | Source: Stocktwits" width="1292" height="308"><figcaption>THTX's Sentiment Meter and Message Volume as of 12:40 p.m. ET on April 11, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user opined that the proposal shows how undervalued the stock is.<stembedurl>https://stocktwits.com/s586576/message/611379645</stembedurl>Another, however, expressed surprise at why the Board did not accept the proposal despite its significant premium.<stembedurl>https://stocktwits.com/RSVinLA/message/611384955</stembedurl><a href="https://stocktwits.com/symbol/THTX">THTX stock</a> has gained nearly 6% in 2025 and about 31% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/jpmorgans-jamie-dimon-sees-sp-500-earnings-estimates-contracting-due-to-trump-tariffs/chfroASRb9j">Jamie Dimon Sees S&amp;P 500 Earnings Estimates Contract As Trump Tariffs Force Companies To Withdraw Guidance</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Rising stock market chart on a trading board background.

Theratechnologies Stock Soars On Acquisition Bid From Future Pak: Retail’s Overjoyed

Future Pak’s proposal offers a cash consideration of $3.51 to $4.50 per share, implying a premium of 164% to 238% on Theratechnologies’ closing price of $1.33 on Thursday.

Equity

Shares of Theratechnologies Inc. (THTX) tumbled 16% on Wednesday after the company’s first-quarter <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.theratech.com/news-releases/news-release-details/theratechnologies-reports-financial-results-first-quarter-2025">earnings</a> fell below Wall Street estimates.Theratechnologies reported a revenue of $19.05 million, marking a growth of 17.2% from the corresponding period last year, but below an analyst estimate of $20.43 million, according to FinChat data.Revenue from the sales of Egrifta SV, used to treat HIV-related excess visceral abdominal fat, jumped by nearly 45% due to higher unit sales and higher selling price.Unit sales rose as the company rebuilt its distributor and pharmacy inventories following a supply disruption resulting in a one-time loss of six to seven weeks of sales.CEO Paul Lévesque said that while the number is mainly related to reloading the pipeline following an end to the temporary supply disruption, the fundamentals of the business and specifically demand for Egrifta SV remains very strong.He added that the HIV portfolio led by the Egrifta franchise will continue to remain an “engine of growth” for years.The company reported positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of $2.3 million, compared to a loss of $247,000 in the same quarter of 2024, but below an estimated $3.93 million.For the fiscal year 2025, the company estimates revenue in the range of $80 million to $83 million and adjusted EBITDA to be between $10 and $12 million, below an estimated $21.16 million.On Stocktwits, retail sentiment around Theratechnologies fell from ‘neutral’ to ‘bearish’ territory, coupled with ‘extremely low’ message volume over the past 24 hours.<figure class="image"><img style="aspect-ratio:651/148;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_09_at_12_04_56_PM_png_e8d5a9a3b7.webp" alt="THTX's Sentiment Meter and Message Volume as of 12:00 p.m. ET on April 9, 2025 | Source: Stocktwits" width="651" height="148"><figcaption>THTX's Sentiment Meter and Message Volume as of 12:00 p.m. ET on April 9, 2025 | Source: Stocktwits</figcaption></figure> <a href="https://stocktwits.com/symbol/THTX">THTX shares</a> have been down nearly 30% this year and over 16% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/bernstein-downgrades-ford-motor-co-cuts-price-target/chfn9uoRbB2">Ford Stock In Spotlight After Bernstein Downgrade, Price Target Cut: Retail Stays Pessimistic</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

Theratechnologies Stock Plummets On Disappointing Q1 Earnings, Full Year Forecast: Retail Sentiment Sours

For the fiscal year 2025, the company estimates revenue in the range of $80 million to $83 million and adjusted EBITDA to be between $10 and $12 million. 

Examining the Future: Theratechnologies's Earnings Outlook

Theratechnologies Faces Potential Supply Disruption For Its Top Selling Drug, Warns of Revenue Impact Due To Manufacturing Delays

Theratechnologies anticipates a temporary supply disruption of Egrifta SV in 2025 due to an FDA-linked manufacturer shutdown, but the company is working to minimize the impact while adjusting revenue...

HIV Medicine Maker Theratechnologies 'Wraps Up Strong Second Quarter,' Stock Soars

Theratechnologies reports Q2 2024 sales of $22.02 million, a 25.5% YoY increase, driven by strong demand for EGRIFTA SV. Net income reached $1 million with an adjusted EBITDA of $5.5 million. The...

Theratechnologies Appoints Elina Tea to its Board of Directors

MONTREAL, April 05, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ( Theratechnologies or the Company ) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...

Theratechnologies to Announce First Quarter 2024 Financial Results and Provide Business Update

MONTREAL, April 03, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ( Theratechnologies or the Company ) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...

Theratechnologies Inc. (NASDAQ:THTX) Short Interest Down 35.7% in March

Theratechnologies Inc. (NASDAQ:THTX - Get Free Report) was the recipient of a large drop in short interest in March. As of March 15th, there was short interest totalling 17,100 shares, a drop of...

Theratechnologies to Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of SORT1+Technology  Platform

Study to assess new camptothecin-peptide conjugates for the treatment of sortilin-positive colorectal cancers Separate data to highlight activity of sudocetaxel zendusortide (TH1902) to trigger the...

Theratechnologies Appoints Jordan Zwick to its Board of Directors

MONTREAL, March 21, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ( Theratechnologies or the Company ) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...

Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montréal, Canada.

Theratechnologies Inc.

0 to 25,000

25,000 to 50,000

50,000 to 75,000

75,000 to 100,000

How many jobs did the U.S. add in September? Vote below + drop your exact prediction in the comments. 
 
*Powered by Polymarket

THTX
Theratechnologies Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest THTX News

THTX Theratechnologies Inc.